Where Innovation is a Tradition


2017 :

  • SLL publishes scientific compendium on BioPerine® black pepper extract
  • Shaheen Majeed named Sabinsa President worldwide
  • SLL’s Curcumin C3 Complex® with BioPerine® shows protective role in lipid profile modification in type 2 diabetes in published study

2016 :

  • SLL’S Boswellin® super reported in Japanese study to show improvement in knee pain
  • European journal publishes article on SLL oil control moisturizer safety and efficacy
  • SLL’s Curcumin C3 Complex® in combination with Omega-3S found to have synergistic effect
  • SLL honored with two pharmexcil awards noting excellence in patents and exports
  • SLL recognized by global health & pharma as the best international life science company and most innovative inflammatory condition treatment
  • SLL recognized for excellence in research and development
  • SLL recognized for export excellence by Karnataka government trade promotion center
  • Muhammed Majeed, Ph.D. honored as industry legend and inducted into the Hall of Legends at Natural Products Expo West, 2016
  • Dr. Majeed, Sabinsa’s founder, honored with Global Innovation & Excellence Award for 110 patents

2015 :

  • SLL patent infringement litigation against prakruti settled: Curcumin C3 Complex® patent successfully defended
  • SLL launches new, nano-free water soluble curcumin form: Uc3 clearTM
  • SLL recognized with two state export excellence awards by visvesvaraya trade promotion centre, Karnataka, India
  • SLL once more successfully protects Curcumin C3 Complex® patent infringement litigation against herbakraft settled
  • SLL expands herb cultivation program founder promotes sustainability, advocates cultivation to protect India’s herbal legacy
  • SLL’s Curcumin C3 Complex® shows significant benefits in lipid levels in patients with coronary artery disease
  • UK study shows SLL’s Curcumin C3 Complex® to be safe adjunct to, and enhance efficacy of, folfox chemotherapy
  • SLL recognized with award for export excellence by Karnataka chamber of commerce
  • Shaheen Majeed appointed to Sami Labs group board of directors
  • SLL honored with two pharmexcil awards noting excellence in patents and exports
  • Curry Powder To Clinical Significance: New book provides a comprehensive understanding of curcumin & studies on Curcumin C3 Complex®

2014 :

  • SLL adds four new patents, bringing worldwide portfolio to 91
  • C3 Reduct® wins Functional Ingredients editors choice award for best science
  • SLL receiveS Best New Product Excellence Award in the raw material category at Panacea-Natural Product Expo India for Saberry®
  • SLL entered into a Memorandum of Understanding with India’s Ayurvedic research organization, Arya Vaidya Sala, Kottakkal (AVS)
  • SLL receives two Pharmexcil awards for 2012 – 2013 in the herbals, ayurveda & nutraceuticals category: The gold award for patents and the silver award for exports in herbals
  • Former President of India, Dr. A.P.J. Abdul Kalam visits SLL
  • SLL introduces new form of coleus with ForsLean® Soft Extract
  • Study shows Boswellia® cream may provide relief for psoriasis
  • SLL initiates lawsuit against four companies for Curcumin C3 Complex® patent infringement
  • SLL’s C3 Complex® shown in study to benefit metabolic syndrome
  • SLL acquires KCP Biotech, expands capacity and adds more colors

2013 :

  • SLL named product Innovator Of The Year
  • SLL breaks ground on additional facility, increasing production 200%

2012 :

  • Curcumin C3 Complex® wins Functional Ingredients editor's choice award in the marketing category
  • New Study says SLL's Curcumin C3 Complex® shows significant reduction in Serum Triglycerides
  • SLL publishes book on Tetrahydrocurcuminoids
  • SLL wins patent in Japan for coleus derived Glaucoma Treatment product

2011 :

  • Sami Labs inks Research Collaboration Agreement with National Institute of Medicinal Materials (NIMM), Ministry of Health, Vietnam for Research & Development of Viatnamese Traditional Medicinal Plants.

2010 :

  • Received the first Patent in China for “Process For Preparing Water Soluble Diterpenes And Their Applications”.
  • Sami Labs inks an agreement with CIPLA to market its drug, Sornip for Psoriasis in Indian Market.
  • Sami’s Kunigal plant near Bangalore, India received Bureau Veritas ISO 22000 Certification.

2009 :

  • American Herbal Products Association - Herbal Industry Leader Award.

2008 :

  • DCGI approves Sami Labs’s natural drug for Psoriasis.
  • NABL accreditation for Laboratories of Sami Labs Limited.
  • Continuous Extraction plant Started at Dobaspet, Karnataka.
  • Sabinsa receives NBJ Supplement Ingredient Product Merit Award for Curcumin C3 Complex®

2007 :

  • Office opened in South Africa for marketing.

2006 :

  • Sami Labs receives the DCGI approval to manufacture and market Ocufors(1% Forskolin - Approval No.MF-6746/06), a natural drug for treating Glaucoma.
  • Awarded a product merit award by Nutrition Business Journal (NBJ) for the brand L- (+) Selenomethionine compound, Selenium SeLECT®, and an Investment in Science and Research award for ForsLean®.
  • Received the 17th US Patent (US Patent # 6,99,8502) for the “A Convenient Process Of Manufacture For Difluromethylornithine and Related Compounds.
  • Received the 16th US Patent (US Patent # 6,982,273) for the “Composition and methods containing bioavailable Se-methyl-L-Selenochysteine for human and veterinary use.

2005 :

  • Received the 4th European Patent (EP1341547) for the “Method of increased nutritional and cosmetic compositions containing active ingredients from the liquid endosperm of fresh green coconuts, and a method for obtaining the active ingredients.
  • Sabinsa's US Patent (No 6,849,645 ) for Tetrahydropiperine received Thomas Alva Edison Patent Award for 2005.
  • Received the 14th US Patent (US Patent #6,849,645) for the “Method of increasedbioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and analogues and derivatives”.
  • Inaguaration of the new manufacturing facility at Kunigal, Karnataka.
  • Sami Labs felicitated its outstanding Coleus cultivators at a function held at Attur in Salem on 18th June.
  • Received the 3rd European Patent (EP0977564) for Forskolin for promoting Lean Body Mass, shifting the proportion of mass in favor of lean body mass, reducing fat tissue and encouraging weight loss.
  • Granted UK patent (GB 2380675) for “Method of increased bioavailability of nutrients and pharmaceutical preparation with tetrahydropiperine and its analogues and derivatives”.

2004 :

  • Sabinsa's US Patent (No5 ,804,596 ) for ForsLean® received the Thomas Alva Edison Patent Award for 2004.
  • US patent #6,689,400 was issued for process of obtaining compositions of stable lutein and lutein derivatives.
  • US patent #6,794,537 was issued for manufacturing process for Se- Methyl-L-Selenocysteine.

2003 :

  • GarliSelect was introduced into the market.
  • Mumbai office opened for marketing and co-ordination of clinical research.
  • Cosmeceutical dosage forms developed for marketing - Johara™ Line of Cosmeceuticals were born.
  • US patent #6,607,712 was issued for Coleus Forskohlii oil for antimicrobial properties.
  • US patent #6,653,327 was issued for Tetrahydrocurcuminoids.
  • MGP Herbal (P) Ltd was acquired by Sami Labs Ltd for fast tracking HerbalCultivation .

2002 :

  • Super-Critical Fluid Extraction facility set up at Nelamangala.
  • DSIR Award for R&D efforts.

2001 :

  • The anti-obesity product Forslean® was voted as the best product of the year by Nutraceutical Industry Association – Nutracon in the US.
  • European patent issued on Bioprotectant composition, method of use and extraction process of Curcuminoids.
  • Office opened in Japan for marketing.

2000 :

  • Biotechnology Center established at Nelamangala, Bangalore.
  • Introduced Cosmecutical ingredients.
  • Tetrahydrocurcuminoids (White Turmeric) was introduced as a skin lightener into the US market. It has become Sami's flagship cosmecutical product.

1998 :

  • Coleus Forskohlii was introduced.
  • It was accepted as a major product for improving body composition.
  • US patent #5,804,596 for Forskohlin composition and use issued.
  • Sami Chemicals and Extracts Pvt Ltd renamed as Sami Labs Limited.

1997 :

  • New Jersey Technology Fast 50 Award.
  • Sabinsa listed again in the Inc 500 companies, ranking # 90.
  • Award for Export Performance for Spice products from President of India.
  • Dr Raj Bammi joins as Director & President, Sami Labs Limited. Dr Bammi holds MSand Ph.D from the University of California, California and has more than 25 years of experience with a major pharma group.

1996 :

  • Sabinsa was listed in the Inc 500 companies, ranking # 70.
  • First US patent awarded for the product Bioperine®.
  • A total Export-Oriented unit established at Kunigal, Bangalore.

1995 :

  • Received Basic Drug Award from President of India .
  • A number of products based on Indian herbal medicines were standardized by Sami research group.

1994 :

  • L-Selenomethionine introduced in India for the first time.

1993 :

  • Manufacturing facility set up at Singasandra.
  • Zinc Picolinate manufactured.

1992 :

  • Hydroxycitric acid from Garcinia Cambogia, Citrin® and Boswellia Serrata® were introduced and became a major export to the US by 1994.
  • R&D facility set up at Singasandra.

1991 :

  • Sami Chemicals and Extracts Pvt Ltd set up in Bangalore.
  • Sami started with the export of Gugulipid® standardized extract.